Embla Medical hf. (CPH:EMBLA)

Denmark flag Denmark · Delayed Price · Currency is DKK
25.63
0.00 (0.00%)
At close: Apr 22, 2025
-16.80%
Market Cap 11.40B
Revenue (ttm) 6.16B
Net Income (ttm) 491.84M
Shares Out 426.65M
EPS (ttm) 1.15
PE Ratio 23.17
Forward PE 20.90
Dividend n/a
Ex-Dividend Date n/a
Volume 14,813
Average Volume 54,437
Open 26.35
Previous Close n/a
Day's Range 25.22 - 26.35
52-Week Range 26.00 - 38.00
Beta 0.57
RSI 35.70
Earnings Date Apr 29, 2025

About Embla Medical

Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neuro Orthotics, Bracing and Supports, and Patient Care. The Prosthetics and Neuro Orthotics segment offers mechanical products, such as lower and upper limb loss or difference; and bionic products microprocessor-controlled feet, knees, hands, fingers, and neuro orthotic joints. Its Bracing and Supports segment provides bracing and... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1971
Employees 4,061
Stock Exchange Copenhagen Stock Exchange
Ticker Symbol EMBLA
Full Company Profile

Financial Performance

In 2024, Embla Medical's revenue was $854.89 million, an increase of 8.81% compared to the previous year's $785.68 million. Earnings were $68.28 million, an increase of 16.94%.

Financial numbers in USD Financial Statements

News

There is no news available yet.